BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.480,29 PKT -6,17 PKT -0,42 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
20.03.12 Swisscom neutral Nomura
20.03.12 Holcim outperform Exane-BNP Paribas SA
19.03.12 UBS buy Citigroup Corp.
19.03.12 Nestlé reduce Nomura
16.03.12 Novartis buy Sarasin Research
16.03.12 Roche outperform Exane-BNP Paribas SA
16.03.12 Novartis neutral Exane-BNP Paribas SA
15.03.12 UBS hold Commerzbank Corp. & Markets
14.03.12 Zurich Insurance buy Sarasin Research
14.03.12 Partners Group neutral Sarasin Research
12.03.12 Nestlé hold ING
09.03.12 Holcim neutral Sarasin Research
09.03.12 UBS neutral WestLB AG
09.03.12 Novartis buy UBS AG
08.03.12 UBS underperform Exane-BNP Paribas SA
08.03.12 UBS buy Citigroup Corp.
08.03.12 Geberit neutral Sarasin Research
07.03.12 Kühne + Nagel International neutral J.P. Morgan Cazenove
07.03.12 Swiss Life neutral J.P. Morgan Cazenove
07.03.12 Novartis neutral J.P. Morgan Cazenove
07.03.12 Nestlé neutral Goldman Sachs Group Inc.
06.03.12 Holcim buy UBS AG
06.03.12 Swiss Life buy Sarasin Research
05.03.12 Kühne + Nagel International neutral Sarasin Research
01.03.12 Sika neutral Sarasin Research
01.03.12 Lindt neutral Sarasin Research
01.03.12 Adecco SA buy Sarasin Research
01.03.12 Holcim neutral Credit Suisse Group
01.03.12 Adecco SA buy ING
01.03.12 Swiss Life hold Société Générale Group S.A. (SG)
29.02.12 ABB (Asea Brown Boveri) neutral Sarasin Research
29.02.12 Swiss Life buy Sarasin Research
29.02.12 Sonova neutral Sarasin Research
29.02.12 Holcim neutral Sarasin Research
28.02.12 Nestlé overweight Morgan Stanley
28.02.12 Swiss Re equal-weight Morgan Stanley
27.02.12 Swiss Re underperform RBC Capital Markets
24.02.12 Swiss Re kaufen Hamburger Sparkasse AG (Haspa)
24.02.12 Swiss Re overweight J.P. Morgan Cazenove
24.02.12 UBS neutral Banc of America Securities-Merrill Lynch